Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zanella

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Science Translational Medicine|August 16, 2023
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancerRobin Beekhof, Andrea Bertotti, Franziska Böttger, et al.
Science Translational Medicine|May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancerElena Grassi, Valentina Vurchio, George D Cresswell, et al.
Nature Communications|August 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patientsSimonetta M Leto, Elena Grassi, Marco Avolio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal CancerAdam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Journal of Translational Medicine|March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinomaFrancesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Science Translational Medicine|August 8, 2020
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotypeBarbara Lupo, Francesco Sassi, Marika Pinnelli, et al.
Nature|September 30, 2015
The genomic landscape of response to EGFR blockade in colorectal cancerAndrea Bertotti, Eniko Papp, Siân Jones, et al.
Cancer Discovery|September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancerMarco Avolio, Simonetta M Leto, Francesco Sassi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Giorgio Corti, Gabriele Picco, et al.
Science Translational Medicine|August 16, 2023
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancerRobin Beekhof, Andrea Bertotti, Franziska Böttger, et al.
Science Translational Medicine|May 21, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancerElena Grassi, Valentina Vurchio, George D Cresswell, et al.
Nature Communications|August 29, 2024
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patientsSimonetta M Leto, Elena Grassi, Marco Avolio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal CancerAdam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
Cancers|October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft ModelsAlice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Journal of Translational Medicine|March 11, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinomaFrancesca Jacobs, Lorenzo Manganaro, Lorenzo D'Ambrosio, et al.
Science Translational Medicine|August 8, 2020
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotypeBarbara Lupo, Francesco Sassi, Marika Pinnelli, et al.
Nature|September 30, 2015
The genomic landscape of response to EGFR blockade in colorectal cancerAndrea Bertotti, Eniko Papp, Siân Jones, et al.
Cancer Discovery|September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancerMarco Avolio, Simonetta M Leto, Francesco Sassi, et al.
Pageof 5